From a clinic-pathological point of view, a diagnosis of Br-NET, although the term tumour, implies an identical treatment to any BC of comparable grade, stage, and hormonal profile, being most Br-NETs hormonal receptors positive. This evidence concerns the gene NR4A1 and neoplasm.